Neoadjuvant Nivolumab for Operable Esophageal Carcinoma

NCT03987815 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Nivolumab

Sponsor

Samsung Medical Center

Collaborators

[object Object]